Security key
52635N103
LENZ Therapeutics, Inc. - Common Stock (LENZ)
CUSIP: 52635N103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 31,105,155
- Total 13F shares
- 29,140,610
- Share change
- +4,411,875
- Total reported value
- $1,355,578,952
- Put/Call ratio
- 327%
- Price per share
- $46.58
- Number of holders
- 166
- Value change
- +$224,909,861
- Number of buys
- 121
- Number of sells
- 26
Report period
Q3 2025
Institutions
166
Top holders
10
LENZ full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
LENZ Therapeutics, Inc. SEC filings
LENZ Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52635N103
Recent filing periods:
Top shareholders of LENZ - LENZ Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. |
13D/G
13F
|
Steven A. Cohen · Company |
4.8%
|
1,357,751
|
$63,244,042 | $0 | 30 Sep 2025 | |
| Paradigm Biocapital Advisors LP |
13F
13D/G
|
Company |
3.8%
from 13D/G
|
1,717,066
|
$50,327,204 | — | 30 Jun 2025 | |
| Versant Venture Capital VI, L.P. |
3/4/5
|
10%+ Owner |
5.8%
|
1,814,726
|
$85,316,256 | -$66,603,139 | 30 Sep 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
|
Company · Director, 10%+ Owner |
13%
|
4,178,823
|
$122,481,302 | — | 30 Jun 2025 | |
| Alpha Wave Global, LP |
13F
|
Company |
12%
|
3,612,211
|
$105,873,904 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.6%
|
1,432,461
|
$41,985,440 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
1,290,994
|
$37,839,035 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.6%
|
1,122,738
|
$32,907,451 | — | 30 Jun 2025 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
3.3%
|
1,017,751
|
$29,830,282 | — | 30 Jun 2025 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
3.1%
|
977,245
|
$28,643,051 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.9%
|
897,616
|
$26,309,125 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
2.8%
|
881,481
|
$25,836,209 | — | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.8%
|
863,389
|
$25,305,932 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
585,355
|
$17,156,754 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
416,122
|
$12,198,387 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
375,728
|
$11,012,588 | — | 30 Jun 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
1.1%
|
343,322
|
$10,062,768 | — | 30 Jun 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.1%
|
343,012
|
$10,053,682 | — | 30 Jun 2025 | |
| Saturn V Capital Management LP |
13F
|
Company |
1.1%
|
342,312
|
$10,033,165 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.86%
|
266,680
|
$7,816,390 | — | 30 Jun 2025 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
0.77%
|
240,000
|
$7,034,400 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.7%
|
217,113
|
$6,363,582 | — | 30 Jun 2025 | |
| SCOGGIN MANAGEMENT LP |
13F
|
Company |
0.64%
|
200,000
|
$5,862,000 | — | 30 Jun 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.59%
|
183,912
|
$5,390,461 | — | 30 Jun 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.59%
|
183,252
|
$5,371,116 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.57%
|
178,214
|
$5,223,452 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.55%
|
171,274
|
$5,020,255 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
170,736
|
$5,004,272 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
142,112
|
$4,165,303 | — | 30 Jun 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.42%
|
131,730
|
$3,861,000 | — | 30 Jun 2025 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.3%
|
93,280
|
$2,734,037 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.27%
|
83,982
|
$2,461,512 | — | 30 Jun 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.27%
|
83,297
|
$2,709,651 | — | 30 Jun 2025 | |
| David M. Knott Jr. |
13F
|
Individual |
0.26%
|
82,000
|
$2,403,420 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.26%
|
81,639
|
$2,392,839 | — | 30 Jun 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.25%
|
77,275
|
$2,264,930 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.24%
|
74,286
|
$2,177,323 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.22%
|
67,978
|
$1,992,435 | — | 30 Jun 2025 | |
| Vivaldi Capital Management LP |
13F
|
Company |
0.19%
|
59,252
|
$1,736,676 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.17%
|
53,943
|
$1,581,070 | — | 30 Jun 2025 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.16%
|
50,041
|
$1,467,000 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
45,810
|
$1,342,691 | — | 30 Jun 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.14%
|
44,231
|
$1,296,409 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
43,954
|
$1,288,292 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
40,886
|
$1,200,197 | — | 30 Jun 2025 | |
| Sovran Advisors, LLC |
13F
|
Company |
0.13%
|
40,423
|
$1,267,665 | — | 30 Jun 2025 | |
| Lisanti Capital Growth, LLC |
13F
|
Company |
0.12%
|
36,185
|
$1,060,582 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.11%
|
34,827
|
$1,020,780 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.1%
|
30,109
|
$882,495 | — | 30 Jun 2025 | |
| KESTRA PRIVATE WEALTH SERVICES, LLC |
13F
|
Company |
0.09%
|
27,304
|
$800,280 | — | 30 Jun 2025 |
Institutional Holders of LENZ Therapeutics, Inc. - Common Stock (LENZ) as of Q3 2025
As of 30 Sep 2025,
LENZ Therapeutics, Inc. - Common Stock (LENZ) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,140,610 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Alpha Wave Global, LP, Versant Venture Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, UBS Group AG, Paradigm Biocapital Advisors LP, 72 Investment Holdings, LLC, TANG CAPITAL MANAGEMENT LLC, and RTW INVESTMENTS, LP.
This page lists
166
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
113
Q3 2025 holders
166
Holder diff
53
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.